Novotech, the global full-service clinical CRO, has published a new report, Small Cell Lung Cancer: Global Clinical Trial ...

The trial met both primary endpoints, with tirzepatide showing a 38% decrease in heart failure outcomes compared to placebo.

Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma ...

Third cohort dose is one million CAR positive cells; ten times higher than the first cohort dose . SAN JOSE, Calif., Nov. 18, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" ...

Presented data at EADV supporting potential of ESK-001 as differentiated oral treatment in immune-mediated diseases through maximal TYK2 inhibition - - Continued to advance three clinical programs ...

Researchers sought to determine the relationship between sleep duration and clinical depression in patients with cardiovascular disease.

Researchers have developed a dual-gene therapy approach to treat Usher syndrome type 1F, a rare condition causing deafness and progressive blindness.

A simplified imaging protocol using just five views still had good accuracy with a median AUROC of 0.85 and normalized mean ...

Researchers have discovered that the Covid-19 virus may hold unexpected benefits for cancer treatment. The virus triggers the ...

Nanoform Finland Plc. November 18, 2024. 08:10 a.m. Finnish time / 07:10 a.m. Swedish time. Nanoform Q3 2024 report: Record number of new projects signed. A ...

Schrödinger has already generated several computational predictive models of off-target drug activity. The company’s recent advances characterizing the structure of safety-related proteins such as ...

Delcath Systems sees strong growth in Q3 earnings, driven by HEPZATO and CHEMOSAT sales. Read my DCTH Q3 earnings analysis.